AstraZeneca PLC
LSE:AZN

Watchlist Manager
AstraZeneca PLC Logo
AstraZeneca PLC
LSE:AZN
Watchlist
Price: 13 592 GBX 0.58% Market Closed
Market Cap: 210.8B GBX

Relative Value

The Relative Value of one AZN stock under the Base Case scenario is hidden GBX. Compared to the current market price of 13 592 GBX, AstraZeneca PLC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AZN Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
30
vs Industry
29
Median 3Y
4.5
Median 5Y
4.6
Industry
2.6
Forward
0
vs History
76
vs Industry
13
Median 3Y
34
Median 5Y
35
Industry
21.7
Forward
0.2
vs History
84
vs Industry
23
Median 3Y
19.7
Median 5Y
21.3
Industry
16.6
vs History
53
vs Industry
16
Median 3Y
40.4
Median 5Y
31.9
Industry
22.5
vs History
30
vs Industry
12
Median 3Y
5.6
Median 5Y
5.5
Industry
2.3
vs History
90
vs Industry
5
Median 3Y
47.2
Median 5Y
47.5
Industry
2.9
Forward
0.4
vs History
95
vs Industry
3
Median 3Y
57.6
Median 5Y
59.2
Industry
5.5
vs History
95
vs Industry
2
Median 3Y
140.3
Median 5Y
157
Industry
13.1
Forward
1
vs History
95
vs Industry
2
Median 3Y
227.4
Median 5Y
258.2
Industry
16.6
Forward
1.2
vs History
95
vs Industry
2
Median 3Y
205.1
Median 5Y
240
Industry
15.8
vs History
95
vs Industry
1
Median 3Y
331
Median 5Y
347.7
Industry
19.1
vs History
79
vs Industry
3
Median 3Y
29.8
Median 5Y
30.1
Industry
1.9

Multiples Across Competitors

AZN Competitors Multiples
AstraZeneca PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP 4.8 29.9 108.4 158.6
US
Eli Lilly and Co
NYSE:LLY
955.6B USD 16.1 51.9 34.9 37.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
485.9B USD 5.3 19.3 15.8 20.5
CH
Roche Holding AG
SIX:ROG
247.5B CHF 4 26.2 11.8 13.4
CH
Novartis AG
SIX:NOVN
205.5B CHF 4.6 17.7 11.3 14.6
US
Merck & Co Inc
NYSE:MRK
248B USD 3.9 13 9.3 11
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.2 9.3 10.8
IE
Endo International PLC
LSE:0Y5F
202.5B USD 87.3 -69.3 321.2 805.4
US
Pfizer Inc
NYSE:PFE
148B USD 2.4 15.1 7.6 10.4
FR
Sanofi SA
PAR:SAN
103.5B EUR 1.5 7.5 6.8 6.8
P/E Multiple
Earnings Growth PEG
UK
AstraZeneca PLC
LSE:AZN
Average P/E: 21.6
29.9
38%
0.8
US
Eli Lilly and Co
NYSE:LLY
51.9
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.3
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.2
29%
0.9
CH
Novartis AG
SIX:NOVN
17.7
17%
1
US
Merck & Co Inc
NYSE:MRK
13
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -69.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
15.1
29%
0.5
FR
Sanofi SA
PAR:SAN
7.5
26%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
AstraZeneca PLC
LSE:AZN
Average EV/EBITDA: 398.4
108.4
10%
10.8
US
Eli Lilly and Co
NYSE:LLY
34.9
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
15.8
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.8
4%
3
CH
Novartis AG
SIX:NOVN
11.3
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.3
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.3
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
321.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
1%
7.6
FR
Sanofi SA
PAR:SAN
6.8
8%
0.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
AstraZeneca PLC
LSE:AZN
Average EV/EBIT: 1 708.3
158.6
23%
6.9
US
Eli Lilly and Co
NYSE:LLY
37.4
36%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.5
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
CH
Novartis AG
SIX:NOVN
14.6
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
1%
10.8
IE
E
Endo International PLC
LSE:0Y5F
805.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.4
8%
1.3
FR
Sanofi SA
PAR:SAN
6.8
15%
0.5